NASDAQ:LMNS - Lumenis Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Lumenis logoLumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians' offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.

Receive LMNS News and Ratings via Email

Sign-up to receive the latest news and ratings for LMNS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:LMNS
CUSIPN/A
Phone+972-4-9599000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins2.40%
Return on Equity6.50%
Return on Assets2.39%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

Lumenis (NASDAQ:LMNS) Frequently Asked Questions

What is Lumenis' stock symbol?

Lumenis trades on the NASDAQ under the ticker symbol "LMNS."

How were Lumenis' earnings last quarter?

Lumenis Ltd (NASDAQ:LMNS) announced its quarterly earnings results on Tuesday, May, 12th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.11 by $0.05. The medical equipment provider had revenue of $68.51 million for the quarter, compared to analysts' expectations of $68.36 million. Lumenis had a net margin of 2.40% and a return on equity of 6.50%. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.07 EPS. View Lumenis' Earnings History.

Who are Lumenis' key executives?

Lumenis' management team includes the folowing people:
  • Harel Beit-On, Chairman of the Board (Age 52)
  • Zipora Ozer-Armon, Chief Executive Officer (Age 51)
  • Ophir Yakovian, Chief Financial Officer
  • Qiying Zhai, Senior Vice President and Regional President, Lumenis China
  • Eran Cohen, Vice President - Global Operations (Age 57)
  • Elad Benjamin, Vice President and General Manager - Surgical Strategic Business Unit
  • Hadas Padan, Vice President and General Manager Vision Strategic Business Unit
  • Roy Ramati, Vice President, General Manager - Aesthetic Strategic Business Unit
  • Kfir Azoulay, Vice President - Corporate Marketing
  • Ido Ben-Tov, Vice President - Service

Has Lumenis been receiving favorable news coverage?

Headlines about LMNS stock have trended positive this week, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Lumenis earned a daily sentiment score of 0.32 on Accern's scale. They also gave media coverage about the medical equipment provider an impact score of 47.40 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for Lumenis.

How do I buy shares of Lumenis?

Shares of LMNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Lumenis?

Lumenis' mailing address is Hakidma 6 Yokneam Industrial Park P.O.B. # 240, YOKNEAM, 2069204, Israel. The medical equipment provider can be reached via phone at +972-4-9599000.


MarketBeat Community Rating for Lumenis (NASDAQ LMNS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  74 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  141
MarketBeat's community ratings are surveys of what our community members think about Lumenis and other stocks. Vote "Outperform" if you believe LMNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LMNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.